Jenburkt Pharmaceuticals P/E Ratio
Current P/E Ratio
12.34
Low Valuation
Low - May indicate good value opportunity
Jenburkt Pharmaceuticals P/E ratio. Jenburkt Pharmaceuticals (JENBURPH) P/E ratio is 12.34 (Low), EPS (TTM) ₹78.71, current price ₹905.55 on NSE — Low - May indicate good value opportunity. Check JENBURPH market cap trends to track the company's total market size over time.
Current Valuation Metrics
P/E Ratio
12.34
Current Price
₹905.55
EPS (TTM)
₹78.71
Exchange
NSE
Valuation Signal
Signal
Fairly Valued
Sector Context
Sector Average
56.41
Sector Median
32.5
Sector Rank
#11 of 199
Sector Percentile
5.5%
JENBURPH P/E Ratio — Valuation Signal & Historical Context
Jenburkt Pharmaceuticals P/E 12.34 — signal: Fairly Valued. For live price, revenue and the complete fundamental profile, see Jenburkt Pharmaceuticals share price chart.
- Stock appears undervalued with PE of 12.34, suggesting potential buying opportunity
- Trading at discount to sector average PE of 56.41
JENBURPH vs Healthcare Peers — P/E Ratio Comparison
Jenburkt Pharmaceuticals P/E 12.34 vs Healthcare average 56.41, median 32.5 — range 2.04–740.29.
Sector Average
56.41
Sector Median
32.5
Lowest P/E
2.04
Highest P/E
740.29
Companies
199
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Sunrest Lifescience | SUNREST | 2.04 | ₹65 | Low |
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Phaarmasia | PHRMASI | 3.41 | ₹63 | Low |
| Sun Pharma Advanced Rese… | SPARC | 3.98 | ₹6,206 | Low |
| Dipna Pharmachem | DPL | 4.57 | ₹12 | Low |
| JFL Life Sciences | JFLLIFE | 4.88 | ₹66 | Low |
| GKB Ophthalmics | GKB | 5.88 | ₹32 | Low |
| Kabra Drugs | KABRADG | 6.09 | ₹44 | Low |
| Royal Sense | ROYAL | 6.58 | ₹47 | Low |
| Colinz Laboratories | COLINZ | 6.62 | ₹18 | Low |